Location: Home
  • search
  • go
  • Relate News
  • 7/25/2016Chinese Scientists to Embark on First Human Trial with CRISPR Gene-Edi...
  • 7/25/2016Updated - CFDA Issues Draft Drug Registration Regulation for Public C...
  • 7/25/2016MOHRSS: NRDL Revision A Major Task This Year
  • 7/22/2016Joint Report of World Bank and WHO Call for Deepened Healthcare Reform
  • 7/22/2016Jilin Zixin Pharma To Acquire 67% of U.S. Genome Firm
  • 7/21/2016CDE Solicits Comments on the Draft Essential Principles for Priority E...
  • 7/20/2016Sinopharm to Lead in SOE Mixed Ownership Reform
  • 7/20/2016Performance Review of Top 100 Chinese Pharmaceutical Companies in 2015
  • 7/20/2016Data Snapshot: Top Ten Listed API, Pharma Formulation and Formulated T...
  • 7/20/2016Beijing, Tianjin and Hebei Reach Agreement for Joint Drug Purchase
  • 7/20/2016Zhejiang BetaPharma, PhIRDA Amends Free Drug Program Following Nationa...
  • 7/19/2016China Bridge Capital Invests CNY 300M in iCarbonX
  • 7/19/2016Healthcare Bond Sales Double in Remedy for China Default Panic
  • 7/19/2016Review of Chinese Pharma Deals, R&D and Regulatory Developments in...
  • 7/19/2016Survey Finds Online Healthcare An Emerging Trend in China
  • 7/19/2016The Transformation and Future of China's Biomedical Innovation
  • 7/15/2016MOHRSS: BMI Reimbursement Scope To Be Expanded in the 13th FYP Period
  • 7/15/2016Half of Provincial Governments Complete Merger of Urban Resident BMI a...
  • 7/15/2016Takeda Plans to Launch Ten New Drugs in China within Five Years
  • 7/15/2016Recent Executive Moves
  • 7/14/2016China Issues Guidance Clarifying Core Tasks and Deadlines for Applicat...
  • 7/13/2016MIIT Reports Chinese Pharma Industry Performance in 2015
  • 7/13/201680% Listed Chinese Pharma Cos Forecast Positive Earnings in H1/2016
  • 7/12/2016Pfizer to Use GE's Mobile Biotech Factory to Make Next-Generation Drug...
  • 7/12/2016Pharmaceutical Trademark Protection in China
  • 7/12/2016GE: There Is a Huge Unmet Need for Affordable Biologics in China
  • 7/12/2016CFDA to Initiate New Round of Clinical Data Inspection with MNCs in th...
  • 7/12/2016Sanming City Establishes Medical Insurance Bureau
  • 7/12/2016Four Chinese Pharma Industry Associations Sign MOU over MR Standards
  • 7/11/2016Huapont, Angionetics Enter Agreement for PE Investment and Development...
  • Page:179/334 Total number of articles:10001: [First][<<] [177] [178] [179] [180] [181] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group